NCT05221593 is a Phase 3 clinical trial of Lithium Carbonate in Neutropenia, sponsored by Al-Azhar University.

Who is sponsoring NCT05221593?

NCT05221593 is sponsored by Al-Azhar University.

What drugs are being tested in NCT05221593?

Interventions in NCT05221593: Lithium Carbonate.

What condition does NCT05221593 study?

NCT05221593 studies Neutropenia.

Is NCT05221593 still recruiting?

NCT05221593 is currently completed. Last updated 21 October 2022.

Last reviewed 2022-10-21 · How we verify

NCT05221593

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Efficacy of Lithium Against Chemotherapy Induced Neutropenia in Breast Cancer Patients

Completed Phase 3 Last updated 21 October 2022

What this trial tests

Phase 3 trial testing Lithium Carbonate in Neutropenia in 50 participants. Completed in 1 June 2022.

Timeline

1 August 2020

Primary endpoint
1 April 2022

1 June 2022

Quick facts

Lead sponsor	Al-Azhar University
Phase	Phase 3
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	prevention
Enrollment	50
Start date	1 August 2020
Primary completion	1 April 2022
Estimated completion	1 June 2022
Sites	1 location across Egypt

Drugs / interventions tested

Lithium Carbonate (lithium carbonate) — full drug profile →

Conditions studied

Neutropenia — all drugs for Neutropenia →

Sponsor

Al-Azhar University

Who can join

Eligibility, any sex, with Neutropenia. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Using Lithium Carbonate to decrease incidence of neutropenia caused by using chemotherapy regimen in breast cancer patients.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Lithium: A Promising Anticancer Agent.
Villegas-Vázquez EY, Quintas-Granados LI, Cortés H, González-Del Carmen M, et al · · 2023 · cited 19× · PMID 36836894 · DOI 10.3390/life13020537

Verify or expand the search:

Other trials of Lithium Carbonate

Trials testing the same drug.

NCT06184581 — Lithium Versus Lamotrigine in Bipolar Disorder, Type II · Phase 4 · recruiting
NCT06424613 — Effects of Lithium on Suicide Prevention in Adolescents and Young Adults With Bipolar Disorder in China · recruiting
NCT05814640 — Sequenced Treatment Alternatives to Relieve Adolescent Depression (STAR-AD) · Phase 1, PHASE2 · recruiting
NCT05402891 — The CHAMP-study: The CHemopreventive Effect of Lithium in Familial AdenoMatous Polyposis · Phase 2 · completed
NCT04623398 — Effect of Lithium in Patients With Autism Spectrum Disorder and Phelan-McDermid Syndrome (SHANK3 Haploinsufficiency) · Phase 3 · completed

Other recruiting trials for Neutropenia

Currently open trials in the same condition.

NCT07434063 — Real-world Study on the Prevention of Neutropenia After Tumor Treatment With Mecapegfilgrastim Injection · recruiting
NCT07066085 — Serial Blood Count Study · EARLY_PHASE1 · recruiting
NCT06537726 — Breath Analysis for the Detection of Invasive Fungal Infections · recruiting
NCT06145321 — Continuous Versus Bolus Administration of G-CSF in Children With Cancer · Phase 4 · active not recruiting
NCT06422533 — Ceftolozane/Tazobactam vs. Piperacillin/Tazobactam for the Treatment of Bacteremia in Hemato-oncological Patients · NA · recruiting

Other Al-Azhar University trials

Trials by the same sponsor.

NCT06489327 — Comparing Two Doses of Oral Melatonin as Premedication in Children Undergoing Surgery · NA · recruiting
NCT07327918 — Effect of Epidural Needle Injection on Catheter Placement Success During Painless Labour · Phase 3 · not yet recruiting
NCT07500194 — Quad Helix vs RME for Posterior Cross-bite in Egyptian Children · NA · not yet recruiting
NCT07360756 — Ultrasonographic ONSD as a Predictor of PDPH in Spinal Anesthesia for Cesarean Delivery · not yet recruiting
NCT07343570 — Comparison of Quadratus Lumborum and Combined Groin Nerve Blocks for Postoperative Analgesia After Open Inguinal Hernia · Phase 3 · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05221593 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Al-Azhar University
Last refreshed: 21 October 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05221593.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing